Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pharmos Corp (PARS)

Pharmos Corp (PARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,179
  • Shares Outstanding, K 58,974
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,980 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/02/14
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0136 +47.06%
on 07/31/20
0.1370 -85.40%
on 07/02/20
+0.0102 (+104.08%)
since 06/30/20
3-Month
0.0063 +217.46%
on 05/29/20
0.1370 -85.40%
on 07/02/20
+0.0136 (+212.50%)
since 04/30/20
52-Week
0.0060 +233.33%
on 11/11/19
0.1370 -85.40%
on 07/02/20
unch (unch)
since 07/30/19

Most Recent Stories

More News
24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury

An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...

TECH : 71.28 (+0.32%)
LLY : 748.01 (-0.25%)
CAPR : 18.62 (+4.67%)
NRX.VN : 0.750 (+2.74%)
NRX : 0.14 (+7.69%)
PARS : 0.0200 (-48.72%)

Business Summary

Pharmos Corporation is a bio-pharmaceutical company that discovers and develops novel therapeutics to treat a range of inflammatory and neurological disorders such as traumatic brain injury and stroke. Theyhave an extensive portfolio of drug candidates under development, as well as discovery, preclinical...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.0536
1st Resistance Point 0.0368
Last Price 0.0200
1st Support Level 0.0084
2nd Support Level 0.0000
3rd Support Level N/A

See More

52-Week High 0.1370
Fibonacci 61.8% 0.0870
Fibonacci 50% 0.0715
Fibonacci 38.2% 0.0560
Last Price 0.0200
52-Week Low 0.0060

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar